Cargando…
Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372389/ https://www.ncbi.nlm.nih.gov/pubmed/34099486 http://dx.doi.org/10.1136/annrheumdis-2021-220049 |
| _version_ | 1783739783628980224 |
|---|---|
| author | Melikhov, Oleg Kruglova, Tatiana Lytkina, Karine Melkonyan, Georgy Prokhorovich, Elena Putsman, Gleb Rodoman, Grigory Vertkin, Arkady Zagrebneva, Alena Stebbing, Justin |
| author_facet | Melikhov, Oleg Kruglova, Tatiana Lytkina, Karine Melkonyan, Georgy Prokhorovich, Elena Putsman, Gleb Rodoman, Grigory Vertkin, Arkady Zagrebneva, Alena Stebbing, Justin |
| author_sort | Melikhov, Oleg |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8372389 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83723892021-09-02 Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals Melikhov, Oleg Kruglova, Tatiana Lytkina, Karine Melkonyan, Georgy Prokhorovich, Elena Putsman, Gleb Rodoman, Grigory Vertkin, Arkady Zagrebneva, Alena Stebbing, Justin Ann Rheum Dis Letter BMJ Publishing Group 2021-09 2021-06-07 /pmc/articles/PMC8372389/ /pubmed/34099486 http://dx.doi.org/10.1136/annrheumdis-2021-220049 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Melikhov, Oleg Kruglova, Tatiana Lytkina, Karine Melkonyan, Georgy Prokhorovich, Elena Putsman, Gleb Rodoman, Grigory Vertkin, Arkady Zagrebneva, Alena Stebbing, Justin Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals |
| title | Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals |
| title_full | Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals |
| title_fullStr | Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals |
| title_full_unstemmed | Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals |
| title_short | Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals |
| title_sort | use of janus kinase inhibitors in covid-19: a prospective observational series in 522 individuals |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372389/ https://www.ncbi.nlm.nih.gov/pubmed/34099486 http://dx.doi.org/10.1136/annrheumdis-2021-220049 |
| work_keys_str_mv | AT melikhovoleg useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT kruglovatatiana useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT lytkinakarine useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT melkonyangeorgy useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT prokhorovichelena useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT putsmangleb useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT rodomangrigory useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT vertkinarkady useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT zagrebnevaalena useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals AT stebbingjustin useofjanuskinaseinhibitorsincovid19aprospectiveobservationalseriesin522individuals |